2 4 6 8 * Sema7a in serum [ng/ml] WT sham 0 Supplementary Figure 2. Plasma values of Sema7a in WT mice undergoing myocardial ischemia and 1 min of reperfusion.
Supplementary Figure 3 . SEMA7A cleavage from human erythrocytes. Human erythrocytes were exposed either to shear stress, hypoxia (2%O 2 ) or normoxia (21% O 2 ) for indicated time points and SEMA7A levels were determined in the supernatant. For comparisons in this figure we performed one-way analyses of variance followed by Dunnett's tests to group "5min unstimulated" (data are mean±SD; n=4/ group; *p < 0.05, ***p < 0.01 as indicated). Figure 4 . SEMA7A does not induce caspase 3 in human myocardial cells (HMCs). a) HMCs were exposed to recombinant human SEMA7A (rhSEMA7A), appropriate Fc control (rhIgG 1 Fc), BSA only or staurosporine for the indicated times, and caspase 3 expression was measured by ELISA. b) HCMs were exposed to SEMA7A, Fc control or BSA only for 6 h and stained for caspase 3 (scale bar 100µm). Staurosporine treatment served as a positive control. Data are mean±SD; n=4;2;4;4;2;4;4;2;3;4;2;4;6, histology n=3. Strategy to identify platelets, neutrophils and plateletneutrophil complexes in the blood and area at risk of animals following myocardial ischemia reperfusion. a) Whole blood platelet -neutrophil aggregates (PNCs) were identified by flow cytometry. Red blood cells were lysed and whole blood samples fixed before flow cytometry acquisition. Whole-blood granulocyte population was focused by granularity (SSC) and expression of surface Ly6G (antibody labeled with BV421); platelet-neutrophil aggregates (PNCs) were recorded as Ly6G + granulocytes labeled positive foranti-platelet CD42b (antibody conjugated with FITC). This whole blood gating strategy was used to retrieve the data shown in Figures 2e, f, g, h; 3g, h, i, j; 6e, f, g, h and Supplementary Figures 7a, b; 9a, b; 13a, b b) After reperfusion, the cardiac area at risk was minced, digested and concentrated for staining with fluorescent antibodies. Tissue granulocytes were identified by their granularity (SSC) and expression of surface Ly6G (antibody labeled with BV421); myocardial plateletneutrophil aggregates (PNCs) were recorded as Ly6G + granulocytes labeled positive with anti-platelet CD42b (antibody conjugated with FITC). This myocardial AAR gating strategy was used to retrieve the data shown in Figures 2i, j k, l; 3k, l, m, n; 6i, j, k, l and Supplementary Figures 7c, d ; 9c, d; 13c, d. For each sample, ³ 10 4 events were acquired on a FACSCanto II, and data were analyzed with FlowJo 10.5. while conducting studies concentrated on platelet function and aggregate formation a platelet threshold has to be set to discriminate background auto-fluorescence from true platelet events 2, 3 . Also in those studies we could identify the presence of platelet-neutrophil aggregates (PNCs) though in minimal concentration due to the discrepancy between platelets and PNC numbers. In summary, only events in whole blood samples or myocardial heart tissues carrying SSC/Ly6G/CD42b positive signal were further examined for their surface expression of CD62P or JON/A. microscopy experiments were performed on n=4 mice with n=10 videos per condition from rmSema7a groups acquired 15minutes after baseline control. d) From the intra-vital-microscopy videos acquired, neutrophil speed (µm / sec n=22;34) was calculated from tracked cells; stationary neutrophils count (cell count / mm 2 n=9;39) platelet sedimentation on the vascular wall was measured (normalized MFI % / mm n=18;29); transmigrated cells from the vasculature after 15min exposure to rmSema7a were count (cell count / mm 2 n=4;35); the distance of transmigrated cells measured in µm (9;177). Intra vital microscopy experiments were performed on n=5 mice with videos of 10 seconds (n=10 videos per condition with 20seconds of interval) from rmSema7a groups acquired 15minutes after baseline control. Data is represented as geometric mean with CI with P values designated as *p<0.05, **p<0.01, ***p<0.001. 
Merge Platelets PMNs

Supplementary Methods
Murine myocardial ischemia and reperfusion model. Mice were anesthetized and placed on a temperature-controlled table to keep body temperature at 37°C. After intubation, ventilation was started, and parasternal thoracotomy was performed to expose the heart. An 8.0 nylon suture (Propylene, Ethicon, Norderstedt, Germany) was placed around the left coronary artery.
Ischemia was induced for one hour by closing the suture and stopped for reperfusion. After the procedure, the heart was excised and blood plasma collected. Myocardium was cut into 0.8mm-thick slices, and myocardial infarct size was ascertained by calculating the percentage of myocardial infarction compared to the area at risk (AAR) of each slice. The areas were identified using a double staining technique with Evans blue and triphenyltetrazolium chloride (TTC) 1 . The area at risk (AAR) and the infarct size were measured by planimetry using ImageJ 1.50i software. In subsets of experiments, blood was taken carefully by cardiac puncture, followed by harvesting the AAR after flushing the blood out after 1 minute or 120 minutes of reperfusion, and both were prepared for flow cytometry and protein measurements. Flow-Cytometric Analysis. Blood was gently withdrawn from the heart left ventricle with a 25-G needle to a syringe coated 1:10 with citrate, and a sample of 100 µl was incubated in tubes previously warmed to 37°C with 1:100 Ab cocktail. Blood samples were stained at 37°C for 30 min in the dark and quickly lysed with warm 1x BD red blood cell lysis buffer (BD 555899), centrifuged at 300×g for 5 min at room temperature and fixed with 1x BD cell fix solution (BD 340181) for 10 min. After centrifugation at 300×g for 5 min at 4°C, samples were acquired in a BD FACSCanto II (BD-Heidelberg). For tissue analysis, the area at risk was collected, minced, and placed in 0.4 mg/ml collagenase (from Clostridium histolyticum -Sigma #C7657) that was diluted in 2% FBS with PBS for 30 min at 37°C for digestion. To inhibit the enzyme and wash the preparation, each sample was centrifuged at 400×g for 5 min at 4°C. After discarding the supernatant, the cellular pellet was resuspended in 1 mg/ml collagenase-dispase solution (Roche #10269638001) and vortexed every 5 min for a total of 20 min and later washed with ice cold HBSS -. After filtration, each heart sample was then concentrated and resuspended in 700 µl of 2% FBS in PBS -. A total of 100 µl of heart sample was incubated with our flow cytometry antibody cocktail for 30 min on ice, washed with ice cold PBSand fixed with 1x BD fixing buffer (BD 340181). run by NIS elements Ar software. Baseline videos were recorded before rmSema7a was administered i.v. and videos acquired after 15min of incubation for 5min in intervals of 20 sec.
Neutrophil speed (µm /sec) was calculated from manually tracked cells, stationary neutrophils count (cell count / mm 2 ), platelet sedimentation on the vascular wall was measured (normalized MFI % / mm), transmigrated cells from the vasculature after 15min exposure to rmSema7a were count (cell count / mm 2 ), the distance of transmigrated cells measured in µm in all videos was processed by NIS elements Ar software 4.20 -64bit (Nikon, Düsseldorf, Germany).
